Mihai Pavalean

Dr. Mihai Pavalean


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Traian ConstantinTraian Constantin
Traian Constantin
MPMihai Pavalean
Mihai Pavalean
SBStefana Bucur
Stefana Bucur
MCMaria Magdalena Constantin
Maria Magdalena Constantin
ANAlin Codrut Nicolescu
Alin Codrut Nicolescu
VMVictor Lucian Madan
Victor Lucian Madan
Background: Bladder cancer (urothelial cancer of the bladder) is the most common malignancy affecting the urinary system with an increasing incidence and mortality. Mouse models of bladder cancer should possess a high value of reproducibility, predictability, and translatability to allow mechanistic, chemo-preventive, and therapeutic studies that can be furthered into human clinical trials. Objectives: To provide an overview and resources on the origin, molecular and pathological characteristics of commonly used animal models in bladder cancer. Methods: A PubMed and Web of Science search was performed for relevant articles published between 1980 and 2021 using words such as: “bladder” and/or “urothelial carcinoma” and animal models. Animal models of bladder cancer can be categorized as autochthonous (spontaneous) and non-autochthonous (transplantable). The first are either chemically induced models or genetically engineered models. The transplantable models can be further subclassified as syngeneic (murine bladder cancer cells implanted into immunocompetent or transgenic mice) and xenografts (human bladder cancer cells implanted into immune-deficient mice). These models can be further divided—based on the site of the tumor—as orthotopic (tumor growth occurs within the bladder) and heterotopic (tumor growth occurs outside of the bladder).

Verified
Journal Article
Open access
PDF file
MPMihai Pavalean
Mihai Pavalean
MDMaria Dobre
Maria Dobre
IPIulia-Andreea Pelisenco
Iulia-Andreea Pelisenco
VMVictor Lucian Madan
Victor Lucian Madan
EMElena Milanesi
Elena Milanesi
MHMihail Eugen Hinescu
Mihail Eugen Hinescu
Bladder cancer (BC) is the most frequent cancer of the urinary system and one of the most common malignancies in the world. In the last decade, many studies have been conducted to better understand the pathophysiological mechanisms of BC to find innovative markers for disease monitoring and treatment. In this study, we aim to identify miRNAs whose expression is associated with specific tumoral characteristics and risks of disease progression. Forty-one BC patients were enrolled in this study. The expression of 84 miRNAs was evaluated by qRT-PCR analysis on tumoral and peritumoral tissues. The results highlighted the association of the miRNA-17-92 cluster with BC, with miR-17-5p, miR-18a-5p, miR-19a-3p, and miR-20a-5p (members of this cluster) being upregulated in the tumoral tissue and correlated with muscle invasion and tumor grading. Taken together, our study identified a panel of 26 dysregulated miRNAs in BC, some of which may be associated with aggressiveness and the risk of progression of this malignancy.

6 January 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Traian ConstantinTraian Constantin
Traian Constantin
MPMihai Pavalean
Mihai Pavalean
SBStefana Bucur
Stefana Bucur
MCMaria Magdalena Constantin
Maria Magdalena Constantin
ANAlin Codrut Nicolescu
Alin Codrut Nicolescu
VMVictor Lucian Madan
Victor Lucian Madan
The journal retracts the article, “Animal Models in Bladder Cancer. Biomedicines 2021, 9, 1762”